Application of Constrained Optimization Methods in Health Services Research: Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force

Autor: Crown, William, Buyukkaramikli, Nasuh, Sir, Mustafa Y., Thokala, Praveen, Morton, Alec, Marshall, Deborah A., Tosh, Jonathan C., Ijzerman, Maarten J., Padula, William V., Pasupathy, Kalyan S.

Publikováno v: In Value in Health September 2018 21(9):1019-1028

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Budget Impact of Belantamab Mafodotin (Belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United States.

Autor: Shah A; Modelling and Simulation, Evidera, Waltham, MA, USA., Tosh JC; Modelling and Simulation, Evidera, London, UK., Ambavane A; Modelling and Simulation, Evidera, London, UK., Nikolaou A; Modelling and Simulation, Evidera, London, UK., Hogea C; Value Evidence and Outcomes, GlaxoSmithKline, Upper Providence, PA, USA., Samyshkin Y; Value Evidence and Outcomes, GlaxoSmithKline, Brentford, UK., Gorsh B; Value Evidence and Outcomes, GlaxoSmithKline, Upper Providence, PA, USA., Maiese EM; Value Evidence and Outcomes, GlaxoSmithKline, Philadelphia, PA, USA., Wang F; Value Evidence and Outcomes, GlaxoSmithKline, Upper Providence, PA, USA.

Publikováno v: ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2021 Sep 10; Vol. 13, pp. 789-800. Date of Electronic Publication: 2021 Sep 10 (Print Publication: 2021).